Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer

NCT07154108 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Head and Neck Cancer (H&Amp;Amp;Amp;N)

Interventions

BIOLOGICAL: recombinant human endostatin adenovirus
DRUG: PD-1 Inhibitor

Sponsor

Sichuan University